Being diagnosed with and treated for cancer often has a strong impact on the life satisfaction (LS) of adolescents and young adults (AYAs). The current study investigated LS in AYA patients with cancer and determined associated factors. METHODS: Young patients (those aged 18-39 years at the time of diagnosis) with all malignant cancer sites and with a diagnosis made within the last 4 years were assessed. LS was measured at 2 measuring time points using the Questions on Life Satisfaction (FLZ-M). Differences in the FLZ-M and the 10 subdomains (friends/acquaintances, leisure activities/hobbies, health, income/financial security, work/profession, housing situation, family life, children/family planning, partnership, and sexuality) between the 2 time points were calculated. Multiple regression analyses were conducted to determine factors associated with LS. RESULTS: A total of 514 patients (386 of whom were women) with a mean age at diagnosis of 29.6 years participated at both measurements. LS increased significantly in 5 domains with a small effect (Hedges g, 0.17) noted over time. The subdomains with the lowest LS were financial and professional situation, family planning, and sexuality. Significant associations with LS were found at baseline for sociodemographic, medical, and psychosocial variables (explained variance [R 2 ] baseline = 0.41). At follow-up, psychosocial factors (positive social support, not having detrimental interactions, and lower perceived adjustment to the disease) remained most important for higher LS controlled for LS at baseline. Neither sociodemographic (except partnership) nor medical factors played a role (R 2 follow-up = 0.54). CONCLUSIONS: Of all the variables examined, social support was found to be the most decisive factor associated with LS at both time points. With regard to LS, social support and adjustment to illness should be given more consideration in the medical care of AYA patients with cancer. Cancer 2018;124:4374-4382.
INTRODUCTION
The cancer incidence among young adults has been increasing in the last few years, 1 and varies substantially by age, sex, and geographical region. 2 The 5-year relative survival of cancer in the adolescent and young adult (AYA) age group is similar to that of patients aged <15 years and is better than that for older adults. 3 The National Cancer Institute defines the widest age range of AYA as being aged 15 to 39 years at the time of diagnosis. 4 AYA patients differ markedly from older patients with cancer with regard to biological and developmental aspects. 5 They are dealing with a serious disease at the time of a complex psychosocial stage in life that includes developmental tasks such as detachment from the parental home, establishing financial and social independence, and the formation of a family, as well as starting a professional career. 6, 7 Being sick with cancer during this sensitive time often results in multiple physical, psychological, and psychosocial limitations such as infertility, 8 changes in physical appearance, 9 fatigue, 10 and disruptions in social life and career. 7, 9 A recent systematic review by Quinn et al 11 of 35 studies revealed that AYA patients with cancer are more likely to have poorer quality of life (QOL) compared with the age-matched general population. Because psychological symptoms such as anxiety and distress develop differently after cancer and are highly interconnected with psychosocial factors, we believe it is safe to assume that QOL also is quite likely to change over time. However, to the best of our knowledge, only a few studies to date have investigated changes in QOL among AYA patients with cancer over time.
Cancer November 15, 2018 QOL is a broad multidimensional concept that usually includes subjective evaluations of both positive and negative aspects of life.
14 Although there are different definitions of QOL, 15, 16 life satisfaction (LS) is a concept strongly related to QOL. [17] [18] [19] LS refers to a subjective appraisal of one's personal life in an number of life domains. LS reports are constructed as ongoing judgments that reflect the influence of changing life circumstances. It can be considered as an indicator of QOL because it reflects how satisfied one is with one's life as a whole. 18 The review by Moons et al of prevalent concepts of QOL in research and practice even suggests that focusing on LS is the most suitable approach for defining QOL. 18 Low LS measures have been shown to be significantly related to poor physical health and poor mental health. 17 There exist many general and illness-specific questionnaires regarding health-related QOL, such as the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30), the Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36), or the Functional Assessment of Cancer Therapy-General (FACT-G). 20 These frequently lack some important and unique concerns of AYA patients with cancer such as employment challenges, fertility and family planning, or body image, 13, 20 ,21 yet all these domains are likely to be affected by illness, especially in AYA patients. Therefore, we evaluated the use of an outcome that has been shown to successfully assess the impact of cancer across multiple domains to supplement other indicators of QOL.
In what to our knowledge are the few existing studies that have been performed regarding QOL in AYA patients with cancer, it has been reported that medical factors such as treatment status (receiving treatment vs being off treatment), 13 more or severe symptoms/somatic late effects, 22 and poorer prognoses 13 are associated with poorer QOL. Relevant sociodemographic risk factors include female sex, 23 a marital status of single, 24 lower educational level, 24 and not having a job or student status. 25 Although to our knowledge associations between psychosocial factors and LS remain understudied, it is known that low levels of social support are associated with lower QOL. 26, 27 Nevertheless, we still know very little regarding which factors associated with QOL remain stable over longer periods of time and therefore could potentially be good points of departure for psychooncological therapies. Thus, the objective of the current study was to describe overall LS in AYA patients with cancer by assessing multiple specific life domains at 2 time points, as well as to detect sociodemographic, medical, and psychosocial factors associated with LS in AYA patients with cancer and which predictors remain stable. The results should help to further determine potential factors associated with LS and aid in the formulation of specific recommendations, thus improving medical and psychosocial care for AYA patients with cancer.
MATERIALS AND METHODS

Study Design
The current study was a prospective longitudinal study with 2 measuring points. Study inclusion criteria were: 1) cancer diagnosis (first manifestation, all malignant tumor identities); 2) age at diagnosis of 18 to 39 years; and 3) cancer diagnosed within the last 4 years. Patients completed the follow-up survey 12 months after the baseline survey.
The study was funded by German Cancer Aid (grant 110948) and received research ethics committee approval (reference number 372-13-16122013) from the ethics board of the medical faculty of the University of Leipzig. Informed consent was obtained from all patients. More details can be found in the study protocol.
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Patient Recruitment and Data Collection
Candidates were informed about and invited to participate in the study at 16 oncological acute care hospitals and 4 rehabilitation clinics, and via 2 tumor registries located over large areas of Germany. In Germany, patients aged <18 years are treated at pediatric oncological facilities and therefore cannot participate in studies without their guardian's explicit permission. In this case, to simplify things, we recruited patients aged 18 to 39 years.
After consenting to take part in the study, patients were provided with either a link for the online survey form (LimeSurvey) or, if so desired, a hard copy of the questionnaire sent by mail. To measure changes that took place after the baseline survey, a follow-up survey with nearly the same instruments was performed 12 months later. More details regarding study recruitment can be found in a previous article. 29 Cancer November 15, 2018
Measurements
All sociodemographic (eg, sex, age at diagnosis [according to Warner et al, 30 we categorized 2 age groups: emerging adulthood (18-25 years) and young adulthood (26-39 years)], children, relationship, housing situation, education, and working status) and medical (eg, cancer diagnosis, treatments, time since diagnosis, additional disease, and status on sick leave) variables were collected via self-report questions. Standardized questionnaires to measure LS, adjustment to illness, and social support were used. 31 at baseline and at follow-up. This instrument evaluates the responder's subjective LS and was developed for use in all age groups. The respondent is asked about the degree of satisfaction within the last 4 weeks in 8 areas of life that usually are relevant to some degree for everyone in the Western world ("How satisfied are you with…: 1) friends/acquaintances; 2) leisure activities/hobbies; 3) health; 4) income/financial security; 5) work/profession; 6) housing situation; 7) family life/children; and 8) partnership/sexuality?") We measured partnership/sexuality as 2 separate items ("partnership" and "sexuality") to allow us to gather information concerning sexuality from both single and partnered patients. For the same reason, we also measured the items "family life" and "children/ family planning" separately instead of treating them as 1 item ("family life/children"). Patients' subjective satisfaction with the resulting 10 domains of life were rated on a 5-point Likert scale, with 1 indicating unsatisfied, 2 indicating rather unsatisfied (categorized as "unsatisfied"), 3 indicating rather satisfied, 4 indicating quite satisfied, and 5 indicating very satisfied (categorized as "satisfied"). A global satisfaction score (FLZ-M global score) was tallied from the mean of the 10 satisfaction values. The FLZ-M is a valid instrument that favors the subjective valuation of functionality in various domains of life. The FLZ-M has a good reliability score (Cronbach α = .82). 31 The psychosocial variable we studied was perceived adjustment/coping to illness ("How much effort does it cost you to cope with your illness?" ["none" to "a great deal"]). It was assessed with a single-item linear analog self-assessment scale of 1 to 100, the Perceived Adjustment to Chronic Illness Scale (PACIS), 32 an instrument that has been validated in several cancer populations.
In addition, illness-specific social support was assessed with the Illness-Specific Social Support Scale Short Version-8 (ISSS-8). The developed 8-item German version 33 is comprised of 2 scales: "positive support" (4 items) and "detrimental interactions" (4 items). Items are scored on a 5-point Likert scale ranging from 0 ("never") to 4 ("always"). A mean value was ascertained for each of the 2 dimensions. The 2 scales demonstrate internal consistencies, with Cronbach alphas of 0.88 and 0.68, respectivley.
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Statistical Analyses
We used SPSS statistical software (version 23; IBM Corporation, Armonk, New York) for all quantitative statistical data analyses. Descriptive frequencies, mean values, medians, standard deviations (SDs), and ranges were used for the data analyses. Frequency differences between baseline and follow-up of sociodemographic, medical, and psychosocial variables were tested using the McNemar chi-square test and the Student t test for paired samples. Differences in LS (FLZ-M global score) and LS subdomains (FLZ-M subdomains) between the 2 time points were performed using Student t tests for dependent groups. A repeated-measure analysis of variance was conducted to compare LS (FLZ-M global score) for both time points in all diagnosis groups. To account for multiple testing, the P value was adjusted to P = .002 (Bonferroni correction). All of the statistical tests conducted were 2-sided.
Factors found to be associated with the FLZ-M global score at baseline and follow-up were determined by hierarchical multiple linear regression analyses by putting the variables in blocks. Independent variables detected at baseline were brought in to determine LS at baseline (model 1), whereas independent variables from the follow-up measurement were used to determine LS at that time point (model 2). In a further model (model 3), we controlled for the FLZ-M global score baseline level. This allows a statement on which variables are associated with changes over time.
Missing values for the items on the FLZ-M, ISSS-8, and PACIS scales at both time points (range, 0-21 missing items) were estimated using the expectation maximization algorithm.
RESULTS
After being screened for inclusion criteria, a total of 762 patients provided written informed consent to participate. Of these candidates, 185 could not be included either because they later declined to participate (43 patients), did
Cancer November 15, 2018 not meet the inclusion criteria in a secondary verification screening (88 patients), or did not complete the questionnaire (54 patients). Thus, 577 patients between the ages of 18 and 39 years at the time of diagnosis completed the baseline survey. With a dropout/failure rate between baseline and follow-up of 11% (63 patients), a total of 514 complete data sets could be analyzed after the 12-month follow-up measurement. More details regarding recruitment can be found in the article by Leuteritz et al. 28 
Sample Characteristics
On average, the patients were aged 29.6 years (SD, 6.1 years) at the time of diagnosis and had been diagnosed with cancer an average of 12.1 months (SD, 8.1 months) before they joined the study ( Table 1 ). The majority of the patients were female (386 patients; 75.1%). The most common diagnoses were breast cancer (139 patients; 27.0%) and Hodgkin lymphoma (93 patients; 18.1%). A small number of patients (7.4%) still were receiving treatment at baseline.
There were significant changes from baseline to follow-up regarding the following characteristics: sick leave status (McNemar chi-square test = 6.899; P < .0001), positive social support (Student t test = 5.406; P < .0001), and perceived adjustment to chronic illness (Student t test = 3.557; P < .0001).
Life Satisfaction
LS (FLZ-M global scores) increased significantly between baseline (mean, 3.39; SD, 0.74) and follow-up (mean, 3.52; SD, 0.76) (P < .00001), with an effect size of Hedges g of 0.17 ( Fig. 1) .
Five of the 10 subdomains demonstrated statistically significant increases from baseline to follow-up with small effect sizes. At both survey time points, patients were most satisfied with the LS subdomains of housing situation, family life, and friends/acquaintances. patients at baseline were least satisfied with the areas of income/ financial security and children/family planning, followed by work/profession. At follow-up, they were least satisfied with sexuality, children/family planning, and income/financial security. The frequencies of patients in the categories of satisfied and unsatisfied for the FLZ-M subdomains can be found in Supporting Table S1 .
Patients with melanoma (17 patients) reported having the highest LS at both measurement points (baseline mean (Table 2 ). No differences were found with regard to any of the 11 cancer diagnoses. There were significant improvements noted between baseline and follow-up LS among the group of patients with solid cancers and for the total sample.
LS and Sociodemographic, Medical, and Psychosocial Factors
Baseline At baseline (model 1), a positive association with LS was found for variables from the 3 blocks of variables: 1) sociodemographic variables (having children, being in a relationship); 2) medical variables (not having an additional disease, not being on sick leave, less time since diagnosis, being off treatment); and 3) psychosocial variables (availability of positive social support, not having detrimental interactions, lower perceived adjustment to the disease) ( Table 3) .
Follow-up
At follow-up (model 2), the same factors remained relevant (with the exception of time since diagnosis) and were joined by the psychosocial variable of working status (employed). At follow-up controlled for FLZ-M baseline level (model 3), only the psychosocial variables were found to be significantly associated with LS: social support (positive social support [P < .001] and detrimental interaction [P = .011]) and perceived adjustment to chronic illness (P < .001). The only psychosocial variable found to be significant was being in a relationship (P = .003). Medical variables did not play a role. The adjusted explained variances of the regression models (R 2 ) were of 0.41 for model 1 (at baseline), an adjusted R 2 of 0.39 for model 2 (at follow-up), and an adjusted R 2 of 0.54 for model 3 (follow-up controlled for FLZ-M baseline level).
DISCUSSION
The LS ratings of AYA patients with cancer were in the upper mid-range at both time points. Even though significant improvements in the FLZ-M global score were noted between the 2 measuring points in 5 of 10 subdomains, the effects were extremely small. Nearly every LS subdomain was rated as being unsatisfactory by approximately one-third of the respondents and that finding remained stable.
The most prevalent areas of life found to be impacted in a negative way were the subdomains of financial and professional situation, family planning, and sexuality. Previous studies have consistently shown that young adults suffer considerably because of cancer-related Cancer November 15, 2018 financial problems. 34, 35 Apart from costs that are directly related to their illness and its treatment, AYA patients also are subject to indirect costs such as lost wages due to being on sick leave, often followed by long-term negative effects on their retirement savings options. As has been true in previous studies, 9 the patients in the current Cancer November 15, 2018 study also indicated being dissatisfied with their professional situations. Bellizzi et al found that nearly 30% of AYAs said that having cancer had had a negative impact on their career plans and finances. 9 Problematic aspects with family planning in AYA patients with cancer have been demonstrated in aspects relating to fertility. 8 The finding that fertility health care costs are significant and not routinely covered by health insurance in either Germany or the United States affects financial and family planning. Our comparison of the FLZ-M subdomains demonstrated that the nonmedical impact of cancer and its treatment on patients can, in fact, be even Abbreviations: ANOVA, analysis of variance; FLZ-M, Questions on Life Satisfaction; SD, standard deviation. a Bold type indicates statistical significance. b P < .0004 extremely significant; P < .0004 very significant; P < .002 significant = type -I-error probalility (Bonferroni-corrected).
Cancer November 15, 2018 more burdensome than the physical symptoms patients experience. Therefore, it is important to sensitize health professionals to the fact that the financial, professional, and family planning situations remain relevant to the LS of patients, even beyond physical symptoms. Care providers need to keep these aspects of their patients' lives in mind and counseling services to address such concerns should be made available to any patient who wishes to use them. Despite the fact that fertility health care costs often are highly burdensome, they still are not routinely covered by health insurance entities in either Germany or the United States. 36 Increasing the coverage of insurance policies for fertility treatments would constitute a momentous advance. Consequently, the specific ways in which cancer can be detrimental to the financial and career development of AYA patients, as well as to family planning and sexuality, need to be studied in more detail, and approaches to alleviating these burdens need to be developed to improve survivorship care.
At both measurement points, patients with sarcoma were found to have the worst FLZ-M scores. These patients frequently must undergo extensive medical treatments that often result in functional disabilities. What is more, these physical impairments often further lead to participation restrictions and reduced physical health. 24 In contrast, patients with melanoma were found to have the highest rates of LS at both measuring points. This may be because of their comparatively high absolute 5-year survival rate of >90%, 37 and the relatively limited extent of medical treatments they experience.
Positive associations with LS were found at baseline for the 3 blocks of sociodemographic (having children, being in a relationship), medical (not having an additional disease, not being on sick leave, less time since diagnosis, being off treatment), and psychosocial (availability of positive social support, not having detrimental interactions, lower perceived adjustment to the disease) variables. One year later, time since diagnosis did not appear to have any Abbreviations: FLZ-M, Questions on Life Satisfaction; ISSS-8, Illness-Specific Social Support Scale Short Version-8; PACIS, Perceived Adjustment to Chronic Illness Scale; R 2 , explained variance. a Independent variables detected at baseline were brought in to determine FLZ-M baseline, whereas independent variables from the follow-up measurement were used to determine FLZ-M at that time point. b Bold type indicates statistical significance. c P < .001. d P < .01. e P < .05 (type I error probability).
Cancer November 15, 2018 association with LS, whereas we found that, in keeping with previous studies, 25 being employed was vital to high LS. This may be related to the fact that workplaces can be a significant source of social support. When we controlled for FLZ-M baseline level, we found to our surprise that only the psychosocial variables were of importance for LS, namely positive social support, not having detrimental interactions, and perceived adjustment to the disease. Neither sociodemographic (except variable partnership, which is closely connected to social support) nor medical factors played a role in LS any longer. Thus, of all the examined variables, social support was the most decisive factor found to be associated with LS at baseline and follow-up. In fact, it had an even greater association with LS than any of the medical or sociodemographic variables. Patients who experience positive social support (eg, those who have someone with whom they can discuss important decisions, someone who encourages and consoles them when they need it) report better LS. Similarly, patients who have a romantic partner report higher LS. This is consistent with previous research on young patients with cancer that found that having someone to talk to was associated with higher levels of psychological well-being. 26 Conversely, patients who experience their loved ones suffering from worry, pessimism, or alarm due to their illness (negative social interactions) report having worse LS. This might be explained, at least in part, by the finding of Kaal et al 27 that a patient's sense of empowerment is closely associated with their QOL. In a similar vein, the results of the current analyses clearly demonstrate that many patients with cancer feel isolated by their illness (as stated by one study participant, "They can't face you, don't know what they should say, and above all, can't deal with having a relationship with you anymore."). Care providers should pay special attention to those patients who lack social support and have higher levels of disease-related burden and include these individuals in suitable supportive care programs. This is particularly true of patients at both time points who do not have partners. Supportive care programs should improve the quality of patients' interactions with those people they are close to by reinforcing positive interactions and diminishing negative interactions. Patients' loved ones necessarily have an important role to play in this process and need to be included. Moreover, providing opportunities for patients to talk with others about the problems they experience (eg, in online communities or patient groups) could improve the LS of AYA patients with cancer. Connecting with someone who is going through a similar experience may be the approach that has the most potential to positively affect their LS. 38 One limitation of the current study was that the majority female sample was imbalanced with regard to sex. Possible reasons for the sex gap in participation rates (such as social desirability phenomenon, different levels of burden, and different coping strategies) have been discussed previously. 28 The sample was heterogeneous with regard to diagnosis, treatment, and time since diagnosis. We controlled for these factors in the regression analysis. A further limitation of the study is that information regarding potentially relevant variables (eg, tumor stage) were not collected. With regard to instrumentation, we separated 2 domains of the original LS measure FLZ-M that may affect the psychometric properties of the measure. Furthermore, information regarding refusal rates was not systematically documented at all of the recruitment settings. This may mean that some subgroups within the AYA cancer population could not be reached.
We believe that the current longitudinal study provides comprehensive data regarding the QOL of AYA patients based on a large heterogeneous patient sample. This is especially useful because the distribution of cancer sites in the sample was largely comparable to that of the German nationwide incidence of cancer in AYAs. 28 Oncologists need to be keenly aware that social support and how an AYA patient with cancer processes the experience of being ill have far greater importance for their LS than sociodemographic or medical factors. The focus of future research should be expanded to include additional parameters such as coping and self-efficacy and empowerment in AYAs.
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